03.04.25 -- What Do We (Really) Know About DNA Quality For In Vitro Transcription?

In early-phase drug development, precise sample preparation for UHPLC testing is crucial to ensure accurate and reliable stability data.

Learn how to select the appropriate species for nonclinical safety studies to ensure regulatory compliance and relevance.

Learn how Pierre Fabre Laboratories streamlined their antibody development with the implementation of a new platform, enabling efficient and multi-parameter stability measurements.

Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.

Using AI tools for retrosynthesis can help you investigate molecules interactively to build a complex API manufacturing process that maintains your timeline and saves you money.